Why is it difficult to enrol patients in clinical cancer research?
1 D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil.
2 Department of Medicine, University of Vassouras, Vassouras, Brazil.
3 Department of Medicine, União Metropolitana de Educação e Cultura (UNIME), Lauro de Freitas, Brazil.
4 Department of Medicine, Faculdade de Tecnologia e Ciências (UNIFTC), Salvador, Brazil.
5 Department of Medicine, Estácio de Sá University, Rio de Janeiro, Brazil
6 Cambridge University Hospitals, Cambridge, United Kingdom.
Short Communication
World Journal of Advanced Research and Reviews, 2020, 06(02), 163-165
Article DOI: 10.30574/wjarr.2020.6.2.0136
Publication history:
Received on 01 May 2020; revised on 20 May 2020; accepted on 21 May 2020
Abstract:
Patient recruitments are a crucial part of clinical research, especially in the medical oncology field. Despite its significance, 2-3% of patients with cancer participate in clinical trials. Beyond the bureaucratic and financial barriers in most trials, the recruitment can be directly impacted by the study design, referrals and patient beliefs. Therefore, this study points out the difficulties related to the process of patient recruitments in oncology, followed by options that contribute to their improvement.
Keywords:
Medical oncology; Clinical trials; Patient recruitments; Referrals; Research; Cancer patients.
Full text article in PDF:
Copyright information:
Copyright © 2020 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0